Cargando…

HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications

BACKGROUND: Diabetic nephropathy has a high cardiovascular risk with a low-level HDL(high density lipoprotein) in epidemiologic studies. Glycated HDL in diabetes can diminish the capacity to stimulate endothelial cell migration, but the mechanism has not been adequately explored in diabetic nephropa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yufeng, Zhao, Mingming, He, Dan, Zhao, Xuyang, Zhang, Wenjing, Wei, Lixin, Huang, Edgar, Ji, Liang, Zhang, Meng, Willard, Belinda, Fu, Zuodi, Wang, Lijuan, Pan, Bing, Zheng, Lemin, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831084/
https://www.ncbi.nlm.nih.gov/pubmed/27074994
http://dx.doi.org/10.1186/s12944-016-0246-z
_version_ 1782427001945063424
author Li, Yufeng
Zhao, Mingming
He, Dan
Zhao, Xuyang
Zhang, Wenjing
Wei, Lixin
Huang, Edgar
Ji, Liang
Zhang, Meng
Willard, Belinda
Fu, Zuodi
Wang, Lijuan
Pan, Bing
Zheng, Lemin
Ji, Linong
author_facet Li, Yufeng
Zhao, Mingming
He, Dan
Zhao, Xuyang
Zhang, Wenjing
Wei, Lixin
Huang, Edgar
Ji, Liang
Zhang, Meng
Willard, Belinda
Fu, Zuodi
Wang, Lijuan
Pan, Bing
Zheng, Lemin
Ji, Linong
author_sort Li, Yufeng
collection PubMed
description BACKGROUND: Diabetic nephropathy has a high cardiovascular risk with a low-level HDL(high density lipoprotein) in epidemiologic studies. Glycated HDL in diabetes can diminish the capacity to stimulate endothelial cell migration, but the mechanism has not been adequately explored in diabetic nephropathy. We performed this study to find out whether HDL in diabetic nephropathy is more dysfunctional than HDL in diabetes without complications. METHODS: Endothelial cells were treated with N-HDL (normal), D-HDL (T2DM[type 2 diabetes mellitus] without complications), DN-HDL (T2DM nephropathy), N-apoA-I (normal apoA-I), and G-apoA-I (glycated apoA-I in vitro). Cell migration capacity was measured with wound-healing and transwell migration assay in vitro and electric carotid injury model in vivo. Protein glycation levels were measured with nanoLC-MS/MS. PI3K expression and Akt phosphorylation were analyzed by western blot. RESULTS: In wound-healing assay, DN-HDL showed a 17.12 % decrease compared with D-HDL (p < 0.05). DN-HDL showed a 29.85 % decrease in comparison with D-HDL (p < 0.001) in transwell assay. In the electric carotid injury model, D-HDL and DN-HDL impaired the re-endothelialization capacity; DN-HDL was less effective than D-HDL. Meanwhile, DN-HDL was found to have a significantly higher protein glycation level than D-HDL (p < 0.001). PI3K expression and Akt phosphorylation were reduced significantly in DN-HDL in comparison with D-HDL and N-HDL. CONCLUSIONS: We found that HDL from diabetic nephropathy has a higher level of glycation and induced less cell migration in vitro and in vivo compared with that from diabetes without nephropathy. This finding suggests that diabetic nephropathy has higher levels of glycated HDL and partially explains why patients with DN have a higher risk of cardiovascular disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-016-0246-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4831084
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48310842016-04-15 HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications Li, Yufeng Zhao, Mingming He, Dan Zhao, Xuyang Zhang, Wenjing Wei, Lixin Huang, Edgar Ji, Liang Zhang, Meng Willard, Belinda Fu, Zuodi Wang, Lijuan Pan, Bing Zheng, Lemin Ji, Linong Lipids Health Dis Research BACKGROUND: Diabetic nephropathy has a high cardiovascular risk with a low-level HDL(high density lipoprotein) in epidemiologic studies. Glycated HDL in diabetes can diminish the capacity to stimulate endothelial cell migration, but the mechanism has not been adequately explored in diabetic nephropathy. We performed this study to find out whether HDL in diabetic nephropathy is more dysfunctional than HDL in diabetes without complications. METHODS: Endothelial cells were treated with N-HDL (normal), D-HDL (T2DM[type 2 diabetes mellitus] without complications), DN-HDL (T2DM nephropathy), N-apoA-I (normal apoA-I), and G-apoA-I (glycated apoA-I in vitro). Cell migration capacity was measured with wound-healing and transwell migration assay in vitro and electric carotid injury model in vivo. Protein glycation levels were measured with nanoLC-MS/MS. PI3K expression and Akt phosphorylation were analyzed by western blot. RESULTS: In wound-healing assay, DN-HDL showed a 17.12 % decrease compared with D-HDL (p < 0.05). DN-HDL showed a 29.85 % decrease in comparison with D-HDL (p < 0.001) in transwell assay. In the electric carotid injury model, D-HDL and DN-HDL impaired the re-endothelialization capacity; DN-HDL was less effective than D-HDL. Meanwhile, DN-HDL was found to have a significantly higher protein glycation level than D-HDL (p < 0.001). PI3K expression and Akt phosphorylation were reduced significantly in DN-HDL in comparison with D-HDL and N-HDL. CONCLUSIONS: We found that HDL from diabetic nephropathy has a higher level of glycation and induced less cell migration in vitro and in vivo compared with that from diabetes without nephropathy. This finding suggests that diabetic nephropathy has higher levels of glycated HDL and partially explains why patients with DN have a higher risk of cardiovascular disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-016-0246-z) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-14 /pmc/articles/PMC4831084/ /pubmed/27074994 http://dx.doi.org/10.1186/s12944-016-0246-z Text en © Li et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Yufeng
Zhao, Mingming
He, Dan
Zhao, Xuyang
Zhang, Wenjing
Wei, Lixin
Huang, Edgar
Ji, Liang
Zhang, Meng
Willard, Belinda
Fu, Zuodi
Wang, Lijuan
Pan, Bing
Zheng, Lemin
Ji, Linong
HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
title HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
title_full HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
title_fullStr HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
title_full_unstemmed HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
title_short HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
title_sort hdl in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831084/
https://www.ncbi.nlm.nih.gov/pubmed/27074994
http://dx.doi.org/10.1186/s12944-016-0246-z
work_keys_str_mv AT liyufeng hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT zhaomingming hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT hedan hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT zhaoxuyang hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT zhangwenjing hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT weilixin hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT huangedgar hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT jiliang hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT zhangmeng hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT willardbelinda hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT fuzuodi hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT wanglijuan hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT panbing hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT zhenglemin hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications
AT jilinong hdlindiabeticnephropathyhaslesseffectinendothelialrepairingthandiabeteswithoutcomplications